doi: 10.3389/fpubh.2025.1519290, 78
Misfolded Chains Peptide chains that assembled in the wrong sequence or orientation structurally different from what you ordered
The employers also attributed other related and desirable outcomes to adding GLP-1s: Higher employee satisfaction/wellbeing (75%) Increased engagement in other wellbeing programs (58%) Improvement in other/comorbid health conditions (57%) Overall, the survey results indicate that cost is not the only reason employers are not providing coverage of GLP-1 medications
Dongmei Zhang, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
GLP-1 receptor agonists slow gastric emptying, which has been hypothesized to affect pancreatic function, though this connection remains speculative and lacks supporting clinical evidence
Optimal metabolic function requires both sufficient hormone production and robust receptor-mediated signaling